RP-TLC determination of the lipophilicity of some new derivatives of 1,2,4-triazole and thiosemicarbazide with potential antituberculosis activity

Journal of Planar Chromatography - Modern TLC

Volumn 19, Issue 107, 2006, Pages 32-41

  Flieger, J ^a   Tatarczak, M ^a   Wujec, M ^a   Pitucha, M ^a   Szumilo H ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

1,2,4 Triazole derivatives; Lipophilicity; Reversed phased TLC; Thiosemicarbazide derivatives

Indexed keywords

DERIVATIVES; EXTRAPOLATION; INTERPOLATION; LIPIDS; NITROGEN COMPOUNDS; POWDERS; VOLUME FRACTION;

LIPOPHILICITY; REVERSED-PHASED TLC; THIOSEMICARBAZIDE DERIVATIVES; TRIAZOLE DERIVATES;

THIN LAYER CHROMATOGRAPHY;

1,2,4 TRIAZOLE DERIVATIVE; ACETONITRILE; METHANOL; ORGANIC COMPOUND; SULFONAMIDE; THIOSEMICARBAZIDE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CALIBRATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG STRUCTURE; LINEAR SYSTEM; LIPOPHILICITY; MATHEMATICAL COMPUTING; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLUTE; STRUCTURE ANALYSIS; THIN LAYER CHROMATOGRAPHY;

EID: 33646229823     PISSN: 09334173     EISSN: None     Source Type: Journal    
DOI: 10.1556/JPC.19.2006.1.6     Document Type: Article

References (27)

1. D. Bleed, C. Watt, and C. Dye, Global Tuberculosis Control, Communicable Diseases, World Health Organisation, Geneva, WHO Report, 2000.
2. WHO report 2005: Global Tuberculosic Control - Surveillance, Planning, Financing.
3. S.M. Holland, Therapy of Mycobacterial Infections, 67th Forum in Immunology, 1996.
4. N.W. Schluger, Principles of Therapy of Tuberculosis in the Modern Era. In: "Tuberculosis" (W.N. Rom and S.M Garay), Lippincott-Raven, New York, 751, 1996.
5. M. Biava, G.C. Porretta, D. Deidda, R. Pompei, A. Tafi, and F. Manetti, Biorg. Med. Chem. Lett. 14 (2003) 515.
6. G. Sbardella, A. Mai, M. Artico, R. Loddo, M.G. Setzu, and P. La Colla, Biorg. Med. Chem. Lett. 14 (2004) 1537.
7. S.G. Kücükgüzel, E.E. Oruc, S. Rollas, F. Sahin, and A. Özbek, Eur. J. Med. Chem. 37 (2002) 197.
8. C.J. Jackson, D.C. Lamb, D.E. Kelly, and S.L. Kelly, FEMS Microbiol. Lett. 192 (200) 159.
9. M.G. Mamolo, D. Zampieri, V. Falagiani, L. Vio, and E. Banfi, Il Farmaco 58 (2003) 315.
10. K. Dabak, A. Sezer, A. Akar, and O.L. Anac, Med. Chem. 38 (22003)215.
11. V. Klimesova, L. Zahajska, K. Waisser, J. Kaustova, and U Möllmann, Il Farmaco 59 (2004) 279.
12. P. Sanna, A. Carta, and M.E.R. Nikookar, Eur. J. Med. Chem. 35 (2000)535.
13. Y.M. Na, M. Le Borgne, F. Pagniez, G. Le Baut, and P. Le Pape, Eur. J. Med. Chem. 38 (2003) 75.
14. A.K. Bakkestuen, L.L. Gundersen, G. Langli, F. Liu, and J.M.J. Nolsoe, Bioorg. Med. Chem. Lett. 10 (2000) 1207.
15. T. Braumann, J. Chromatogr. 373 (1986) 191-225.
16. R. Kaliszan, J. Chromatogr. 220 (1981) 71-83.
17. M. Dobosz, M. Pitucha, and M. Wujec, Acta Pol. Pharm. - Drug Res. 53 (1996) 31-38.
18. M. Dobosz and M. Sikorska, Acta Pol. Pharm. - Drug Res. 51 (1994) 369-376.
19. M. Dobosz, M. Struga, A. Chodkowska, E. Jagiełło-Wójtowicz, K. Stepniak, and A. E. Kozioł, Acta Pol. Pharm. - Drug Res. 59 (2002) 281-290.
20. A.A. Ikizler, B. Kahveci, C.B. Johansson, C. Celik, and H. Yüksek, Acta Pol. Pharm. - Drug Res. 54 (1997) 307-312.
21. ChemPlus v.2.0/HyperChem v. 5.1, distributed by Hypercube, USA, 1997.
22. E. Soczewiński and C.A. Wachtmeister, J. Chromatogr. 7 (1962) 311-320.
23. G.L. Biagi, A.M. Barbaro, A. Sapone, and M Recanatini, J. Chromatogr. A.662 (1994) 341-361.
24. K. Valko and P. Sleger, J. Chromatogr. A 631 (1993) 46-61.
25. J. Flieger B. Modzelewska-Banachiewicz, H. Szumiło, and M. Tatarczak, Chromatographia 60 (2004) S291-S294.
26. G.L. Biagi, A.M. Barbaro, A. Sapone, and M. Recanatini, J. Chromatogr. A 669 (1994) 246.
27. J. Flieger, M. Tatarczak, and H. Szumilo, Chromatographia, in press.